BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16639747)

  • 1. Structure of a glutathione conjugate bound to the active site of aldose reductase.
    Singh R; White MA; Ramana KV; Petrash JM; Watowich SJ; Bhatnagar A; Srivastava SK
    Proteins; 2006 Jul; 64(1):101-10. PubMed ID: 16639747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of human aldose reductase holoenzyme in complex with statil: an approach to structure-based inhibitor design of the enzyme.
    El-Kabbani O; Ramsland P; Darmanin C; Chung RP; Podjarny A
    Proteins; 2003 Feb; 50(2):230-8. PubMed ID: 12486717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrahigh resolution drug design. II. Atomic resolution structures of human aldose reductase holoenzyme complexed with Fidarestat and Minalrestat: implications for the binding of cyclic imide inhibitors.
    El-Kabbani O; Darmanin C; Schneider TR; Hazemann I; Ruiz F; Oka M; Joachimiak A; Schulze-Briese C; Tomizaki T; Mitschler A; Podjarny A
    Proteins; 2004 Jun; 55(4):805-13. PubMed ID: 15146479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective recognition of glutathiolated aldehydes by aldose reductase.
    Ramana KV; Dixit BL; Srivastava S; Balendiran GK; Srivastava SK; Bhatnagar A
    Biochemistry; 2000 Oct; 39(40):12172-80. PubMed ID: 11015195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the glutathione binding site of aldose reductase.
    Ramana KV; Dixit BL; Srivastava S; Bhatnagar A; Balendiran GK; Watowich SJ; Petrash JM; Srivastava SK
    Chem Biol Interact; 2001 Jan; 130-132(1-3):537-48. PubMed ID: 11306073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic and structural characterization of the glutathione-binding site of aldose reductase.
    Dixit BL; Balendiran GK; Watowich SJ; Srivastava S; Ramana KV; Petrash JM; Bhatnagar A; Srivastava SK
    J Biol Chem; 2000 Jul; 275(28):21587-95. PubMed ID: 10764810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and kinetic determinants of aldehyde reduction by aldose reductase.
    Srivastava S; Watowich SJ; Petrash JM; Srivastava SK; Bhatnagar A
    Biochemistry; 1999 Jan; 38(1):42-54. PubMed ID: 9890881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing flexibility and "induced-fit" phenomena in aldose reductase by comparative crystal structure analysis and molecular dynamics simulations.
    Sotriffer CA; Krämer O; Klebe G
    Proteins; 2004 Jul; 56(1):52-66. PubMed ID: 15162486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrahigh resolution drug design I: details of interactions in human aldose reductase-inhibitor complex at 0.66 A.
    Howard EI; Sanishvili R; Cachau RE; Mitschler A; Chevrier B; Barth P; Lamour V; Van Zandt M; Sibley E; Bon C; Moras D; Schneider TR; Joachimiak A; Podjarny A
    Proteins; 2004 Jun; 55(4):792-804. PubMed ID: 15146478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of rat aldose reductase-like protein AKR1B14 holoenzyme: Probing the role of His269 in coenzyme binding by site-directed mutagenesis.
    Sundaram K; Dhagat U; Endo S; Chung R; Matsunaga T; Hara A; El-Kabbani O
    Bioorg Med Chem Lett; 2011 Jan; 21(2):801-4. PubMed ID: 21168333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alrestatin double-decker: binding of two inhibitor molecules to human aldose reductase reveals a new specificity determinant.
    Harrison DH; Bohren KM; Petsko GA; Ringe D; Gabbay KH
    Biochemistry; 1997 Dec; 36(51):16134-40. PubMed ID: 9405046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldose and aldehyde reductases: structure-function studies on the coenzyme and inhibitor-binding sites.
    El-Kabbani O; Old SE; Ginell SL; Carper DA
    Mol Vis; 1999 Sep; 5():20. PubMed ID: 10493777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution structures of human aldose reductase holoenzyme in complex with stereoisomers of the potent inhibitor Fidarestat: stereospecific interaction between the enzyme and a cyclic imide type inhibitor.
    El-Kabbani O; Darmanin C; Oka M; Schulze-Briese C; Tomizaki T; Hazemann I; Mitschler A; Podjarny A
    J Med Chem; 2004 Aug; 47(18):4530-7. PubMed ID: 15317464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The crystallographic structure of the aldose reductase-IDD552 complex shows direct proton donation from tyrosine 48.
    Ruiz F; Hazemann I; Mitschler A; Joachimiak A; Schneider T; Karplus M; Podjarny A
    Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1347-54. PubMed ID: 15272156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution crystal structure of aldose reductase complexed with the novel sulfonyl-pyridazinone inhibitor exhibiting an alternative active site anchoring group.
    Steuber H; Zentgraf M; Podjarny A; Heine A; Klebe G
    J Mol Biol; 2006 Feb; 356(1):45-56. PubMed ID: 16337231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
    Ruiz FX; Cousido-Siah A; Mitschler A; Farrés J; Parés X; Podjarny A
    Chem Biol Interact; 2013 Feb; 202(1-3):178-85. PubMed ID: 23295227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution neutron protein crystallography with radically small crystal volumes: application of perdeuteration to human aldose reductase.
    Hazemann I; Dauvergne MT; Blakeley MP; Meilleur F; Haertlein M; Van Dorsselaer A; Mitschler A; Myles DA; Podjarny A
    Acta Crystallogr D Biol Crystallogr; 2005 Oct; 61(Pt 10):1413-7. PubMed ID: 16204895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of aldehyde reductase holoenzyme in complex with the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
    El-Kabbani O; Carbone V; Darmanin C; Oka M; Mitschler A; Podjarny A; Schulze-Briese C; Chung RP
    J Med Chem; 2005 Aug; 48(17):5536-42. PubMed ID: 16107153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Cys-298 in specific recognition of glutathione by aldose reductase.
    Sekhon G; Singh B; Singh R
    J Biomol Struct Dyn; 2022 Sep; 40(15):6880-6888. PubMed ID: 33627036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldose reductase catalyzes reduction of the lipid peroxidation product 4-oxonon-2-enal.
    Doorn JA; Srivastava SK; Petersen DR
    Chem Res Toxicol; 2003 Nov; 16(11):1418-23. PubMed ID: 14615967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.